Cambrex

From all of us at Cambrex, season's greetings and best wishes for the new year.

Did you know you can download our whitepapers from our website? Recent topics include nitrosamines analysis, global onshoring trends, and benefits of outsourcing stability storage. Seach topics and read more here: https://lnkd.in/gFwM_teD #Nitrosamines #CDMO #Partnerships #StabilityStorage 

We thoroughly enjoyed attending the Advancing Drug Development Forum yesterday. It was an excellent program with stimulating dialogue, insightful discussions, and opportunities to connect with industry leaders. 

Did you know you can view past webinars by #CambrexExperts on-demand? We have spoken on a variety of topics including peptide-based therapeutics, CDMO partnerships and global onshoring trends, continuous flow, and stability storage. Watch Now: https://lnkd.in/gKA5vnJM #CDMO #PharmaWebinar #Peptides #LifeSciences #Partnerships  #ContinuousFlow #FlowChemistry #StabilityStorage #StabilityStudies

We are excited to share that Cambrex has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for Lilly’s biotech collaborators.  Through this agreement, Cambrex will partner with Lilly Catalyze360-ExploR&D, Lilly’s early external innovation and collaboration arm, to provide drug substance, drug product, analytical service labs and R&D expertise to Lilly Catalyze360 biotech collaborators, with services hosted at Cambrex’s early development center of excellence in Longmont, Colorado. Read the full press release here: https://lnkd.in/eHQVZnbg

It's your last chance to register for tomorrow's webinar, "Removing the Headache: Outsourced Stability Storage and Testing Solutions." Hear from Stephen Delaney, Managing Director at Q1 Scientific, and Darryl Souness, Head of Analytical at Cambrex Edinburgh, as they discuss risk mitigation and cost management when outsourcing stability storage, creation of thorough stability study protocols, and more. Be sure to join us! Free to Register: https://lnkd.in/gWKmcDfp #stabilitystorage #pharma

Cambrex is excited to be a sponsor of the Advancing Drug Development Forum in Cambridge next week. Hear from our own Matthew Bio, CSO of Cambrex and President of Snapdragon Chemistry participate on a panel discussing lessons learned from CRO/CDMO entrepreneurial founders. Click here to schedule a meeting with Cambrex: https://lnkd.in/g8-bUcMH   Andy Miles & Mark Eugenio #ConnectWithCambrex 

As part of our video series, “A Different Brand of Experts,” we invite you to meet Shawn Conway, Ph.D. and Senior Director of Operations at Cambrex in High Point, North Carolina. Shawn is one of our most tenured continuous flow experts as well as part of the site leadership team.   When asked why he chose to work in the CDMO industry, Shawn shared: "Working for a CDMO provides a unique opportunity to tackle a range of challenges and you interact with many different people and clients. It’s constantly changing and truly about improving people’s lives.” Watch the video to hear more from Shawn: https://lnkd.in/g_Q98Ccn #continuousflow

In the ever-evolving pharmaceutical landscape, reliable #stabilitystorage is becoming increasingly essential for companies looking to stay compliant, reduce costs, and improve operational efficiency. Read our recent whitepaper with Q1 Scientific to learn about the strategic benefits of outsourcing stability storage and discover a comprehensive guide on how to select the right partner for your needs. Click to download: https://lnkd.in/giTvzcdp

Outsourcing stability storage and testing can help #pharma and #medicaldevice companies achieve stability program excellence and gain a competitive edge in the market. Working with the right partner can remove headaches around cost, risks associated with aged equipment or missed stability pulls, possible lack of compliance and more. Join our experts Stephen Delaney and Darryl Souness on December 4th as they discuss the merits of outsourcing #stabilitystorage and #stabilitystudies. Register here: https://lnkd.in/gWKmcDfp